CEDIA Benzodiazepine Assay

CEDIA Benzodiazepine Assay is an FDA 510(k)-cleared medical device (K190968) manufactured by Microgenics Corporation. This device is classified under the Clinical Toxicology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on December 8, 2019. Regulation: 8.